The Gilliam Autism Rating Scales-3rd Edition (GARS-3) is widely utilized, but evidence regarding its psychometric properties is limited and equivocal. The current study attempted to create a shorter GARS-3, to be utilized for screening purposes, via exploratory factor analysis. Archival data from 183 clinically referred children ( age = 9.03; autism spectrum [AUT], = 86; Not-Autism Spectrum [NOT], = 97) who received comprehensive assessments with the Autism Diagnostic Observation Schedule-2nd Edition (ADOS-2) were analyzed. Retention of items with factor loadings > .70 resulted in a 21-item (∝ = .92), 5-factor measure (SF21) that was invariant across AUT/NOT groups to the scalar level. Evidence for discriminant validity with the Child Behavior Checklist was moderate; evidence for concurrent and criterion validity was weak to poor. Similar to multiple prior studies, sensitivity and specificity could not be optimized at a given cutoff. Neither the GARS-3 nor the GARS-3SF21 is recommended for autism diagnosis in complex clinically referred samples. Patterns of findings that could be used to improve autism questionnaires are identified and discussed.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: | December 10, 2024
Journal of Pediatric Neuropsychology – Scholars Portal